IC
AXSM icon

IEQ Capital’s Axsome Therapeutics AXSM Stock Holding History

IEQ Capital’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Sell
8,835
-560
-6% -$96.7K 0.01% 884
2025
Q4 		$1.72M Sell
9,395
-1,425
-13% -$199K 0.01% 846
2025
Q3 		$1.31M Buy
10,820
+2,972
+38% +$335K ﹤0.01% 911
2025
Q2 		$819K Buy
7,848
+3,032
+63% +$321K 0.01% 931
2025
Q1 		$562K Buy
+4,816
New +$549K ﹤0.01% 931

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IEQ Capital's AXSM Position: Q1 2026 in Review

IEQ Capital reduced its Axsome Therapeutics (AXSM) stake by 6% in Q1 2026, selling an estimated $96.7K and leaving 8,835 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #884.

IEQ Capital first reported a position in AXSM in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.72M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • IEQ Capital held 8,835 shares of Axsome Therapeutics worth $1.49M as of Q1 2026.
  • IEQ Capital sold 560 Axsome Therapeutics shares in Q1 2026, an estimated $96.7K.
  • Axsome Therapeutics made up 0.01% of IEQ Capital's portfolio in Q1 2026, its #884 holding.
  • IEQ Capital first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • IEQ Capital's Axsome Therapeutics position peaked at $1.72M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.